Kenya receives consignment of 21,000 starter doses of Lenacapavir (PrEP)

2026-02-18 - 11:45

Kenya has received an initial consignment of 21,000 starter doses of the long-acting injectable HIV pre-exposure prophylaxis (PrEP), Lenacapavir, marking the first phase of a national rollout and reinforcing the country’s commitment to innovative, people-centred strategies to end the HIV epidemic. Delivered in partnership with the Global Fund, the shipment represents a major milestone in...